Takayuki Iwamoto
Overview
Explore the profile of Takayuki Iwamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsubara Y, Suganuma N, Nakamoto S, Kikawa Y, Iwamoto T, Yamanaka T, et al.
Breast Cancer
. 2025 Feb;
PMID: 39939473
Background: In the realm of surgical therapy for cN0 early breast cancer, sentinel lymph node biopsy (SNB) has been established as a technique that allows the omission of axillary lymph...
2.
Nakayama S, Iwamoto T, Araki K, Narui K, Nakayama T, Nagase H, et al.
Breast Cancer
. 2025 Feb;
PMID: 39928253
Background: The safety of combination therapy with abemaciclib and hormone therapy in patients with hormone receptor-positive (HR +), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) who...
3.
Nagahashi M, Kumamaru H, Kinukawa N, Iwamoto T, Kawashima M, Kinoshita T, et al.
Breast Cancer
. 2025 Feb;
32(2):217-226.
PMID: 39910023
This is an annual report by the Japanese Breast Cancer Society, which provides statistics on the clinical data on breast cancer in Japan, extracted from the National Clinical Database-Breast Cancer...
4.
Iwamoto T, Nozaki Y, Inoue T, Suda T, Mizumoto R, Arimoto Y, et al.
J Gastroenterol
. 2024 Nov;
60(2):197-209.
PMID: 39585387
Background: The histological improvement in liver fibrosis in patients with hepatitis C who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) treatment has not been comprehensively investigated. Therefore,...
5.
Nakayama S, Yoshizawa A, Tsurutani J, Yoshimura K, Aoki G, Iwamoto T, et al.
Breast Cancer
. 2024 Nov;
32(1):177-185.
PMID: 39556171
Purpose: The exact incidence of and risk factors for interstitial lung disease (ILD), a serious side effect of abemaciclib, remain unknown in real-world settings. We examined the incidence of and...
6.
Kuba S, Soutome S, Hagiwara Y, Kikawa Y, Iwamoto T, Sangai T, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):172-175.
PMID: 39354670
Stomatitis, which is a common side effect of chemotherapy, currently lacks a standardized approach for its prevention. Therefore, this multicenter, randomized, open-label, controlled phase III trial aims to assess the...
7.
Nakamoto S, Iwamoto T, Taira N, Kajiwara Y, Kawada K, Takabatake D, et al.
Breast Cancer
. 2024 Jul;
31(5):969-978.
PMID: 38980571
Background: Although the association between higher physical activity and preventive effect on breast-cancer-related lymphoedema (BCRL) has been reported, it is unclear what intervention is optimal. We aimed to investigate the...
8.
Iwamoto T, Niikura N, Watanabe K, Takeshita T, Kikawa Y, Kobayashi K, et al.
Breast Cancer Res Treat
. 2024 Jun;
208(2):253-262.
PMID: 38922548
Purpose: This study aimed to determine whether the 21-Gene Breast Recurrence Score® assay from primary breast tissue predicts the prognosis of patients with hormone receptor-positive and human epidermal growth factor...
9.
Nakamoto S, Kajiwara Y, Taniguchi K, Hida A, Miyoshi Y, Kin T, et al.
Breast Cancer Res Treat
. 2024 Jun;
208(1):67-77.
PMID: 38888797
Purpose: Various studies have demonstrated the causal relationship between gut microbiota and efficacy of chemotherapy; however, the impact of gut microbiota on breast cancer has not been fully elucidated. This...
10.
Nakamoto S, Shien T, Iwamoto T, Kubo S, Yamamoto M, Yamashita T, et al.
Sci Rep
. 2024 Apr;
14(1):9869.
PMID: 38684839
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) are the standard agents for treating patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer (ER + HER2 ...